BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2012
View Archived Issues
FGF-21 analogue fusion protein developed for treating diabetes
Read More
KinDex Therapeutics describes novel agent for diabetes
Read More
Human growth hormone analogue displays extended half-life in vivo
Read More
New triple combination therapy now available for H. pylori infection
Read More
Inovio kicks off phase I study of H1N1 vaccine
Read More
Sobi and Affibody enter new research agreement
Read More
Scientists in Taiwan discover new candidate marker of HCC prognosis
Read More
SRI International obtains Department of Defense grant
Read More
Genisphere and LIMR continue collaboration
Read More
ChemDiv Research Institute and Abbott to launch new projects
Read More
Abbott Laboratories presents novel calpain-1 inhibitors
Read More
Research in Norway yields new Wnt signaling inhibitors
Read More
Collaboration produces novel DAPD prodrugs
Read More
Lycera patents new mitochondrial F1F0 ATPase hydrolase inhibitors
Read More
New candidate dsRNA drugs discovered at Alnylam Pharmaceuticals
Read More
Novel cell migration modulators designed in Japan
Read More
Immune Response BioPharma plans phase III trial of rheumatoid arthritis vaccine
Read More
XenoPort receives grant for preclinical XP-23829 studies
Read More
Trial assessing drug for acute schizophrenia does not meet endpoint
Read More
Dosing begins in first-in-human Adipotide study
Read More
Evotec licenses molecules to Janssen
Read More
TiGenix begins enrollment in pivotal phase III trial
Read More
Noxxon launches phase IIa study in chronic lymphocytic leukemia
Read More
BioMimetic Therapeutics submits amendment to Augment bone graft PMA
Read More
Hemispherx reaches agreement with FDA on filing requirements for Ampligen NDA
Read More
Merus Labs acquires rights to drug for overactive bladder
Read More
Recruitment complete in phase III NX-1207 trial
Read More
Novel candidate hepatitis therapies divulged
Read More